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INTRODUCTION
Could you prevent the death of a person poisoned with a
cholinesterase inhibiting agent?

If you can answer this yes, then

I ask you if you could successfully treat several patients at once
with this poisoning?

Our society in the near future may place this

challenge upon you.
Maybe you answered "No" to both the above questions and ask,
It¥<)hat is a cholinesterase-inhibiting agent?"
In 1939 a German scientist by the name of Schrader was searching for a more effective insecticide and discovered "Nerve Gas", a
cholinesterase-inhibiting agent.

Since this discovery, .many re-

finements have been made on this agent and now it can be used as the
base for excellent insecticides and has potential use as a "war gaslt
against man.
My purpose in this paper is to present

SOIOO

of its military po-

tential, medical uses, mode of action, present concepts in treatment,
and some of the unusual problems that may present themselves to medical personrlel in the event that this agent is used against large
populations, either rrilitary or civilian.
World i7a.r I proved the effectiveness of chemical warfare.
difficult lesson learned must not be forgotten quickly.

A

This lesson

was given in April 1915 by the Germsns Vllhen they released chlorine
gas against the Allies in France.

The effect of this type of vmrfare

was profound and demoralizing, and the casualties were many.
1

The Germans developed a compound

YJlOYIITI

as Tabun, a nerve gas

and cholinesterase-inhibitive agent in World War II.
of the war a large

C~rn~n

At the close

plant for the manufacture of Tabun was

captured by the Russians and rreved back to Russia.

So we know that

other countries can manufacture these agents.
Since World War I gas warfare has not been used, either because
of International Rules of Warfare or the fear that the opponent may
retaliate in kind if used a gainst him.

However, nuclear weapons

with their vast devastating powers have been used in the past and
are in future plans in certain cases.

Therefore if these awesome

weapons are under consideration for use, one must assume that chemical agents are under consideration for use.

-

Some of the reasons that cholinesterase-inhibiting agents may
be used in future warfare are the following:
1.

Not all countries in the world can afford financially to
develop nuclear weapons, nor do they have the sc:i.entists
to develop and perfect them.

2.

Cholinesterase-inhibiting agents are easy to produce and
there is an abundance of raw material.
p~~er

3.

Any major military

could produce hundreds of tons of this agent per day.

Therefore it is possible that a small nation without nuclear weapons could wage war just as effectively in terms
of death to the enemy, using cholinesterase-inhibiting agents, as theircpponents could with nuclear weapons.
2

Recently L. J. LeRoux, vice president of the National Council
for Scientific and Industrial Research, stated that South African
scientists are working on "deadly gases" as a low cost military
weapon that can cause massive devastation comparable to that from
nuclear weapons.

Cholinesterase-inhibiting agents also have these

advantages:
1.

'Ibey could be used in a way that identification of the aggressor would be impossible.

2.

These agents are colorless, odorless and cause no irritation to the body that give warning of exposure until the
patient has been seriously poisoned.

-

Therefore identifica-

tion of the agent or the attack may be too late.

3. Saboteurs could spread these agents against large cities or
military bases with little chance of being detected.

4. These agents are at least twice as lethal as any previously known chemical agent.

In fact one deep breath or a few

droplets of this agent on skin may result in death.

The

time between exposure and death may be seconds.

5. It is conceivable that these agents can be delivered by
aircraft or long range missiles.

6.

These agents do not destroy property and once the area has
been decontaminated, either through human efforts or natures
method of time and weather, the area may be occupied and
its industry utilized.
3

The above introduction gives only a few of the reasons why
this type of poisoning may be seen in the mass casualty situation
in the future.

If you still aren't convinced that this type of poisoning

may be a common one in the future and justifies your knowing how to
treat this poisoning, then let us proceed to its use as an insecticide.

The cholinesterase-inhibitor agents constitute the base of

many of the commercial insecticides today.

Certainly the insecti-

cides aren't as lethal in small concentrations as the "war gases",
but workers spraying fields can easily become dangerouslY
inated with large doses of them.

conta~

Contamination can take place

either by inhalation, through the skin, or by ingestion.

The know-

ledge of the possible routes of poisoning can lead the imagination
to supply thousands of possible ways that people handling insecticides could accidently be poisoned.
Cholinesterase-inhibiting agents are also used medically in the
treatment of glaucoma, myasthenia gravis, and abdominal distention.
Therefore prescribing or ingesting toxic doses in the treatment of
the above medical problems could also lead to the same type poisoning.

FUNCTIONS OF ACETYLCHOLINE
The name of the type of poisoning suggests its action.

Cholines-

tera.a-inhibiting agents act as an irreversible inhibitor of the enzyme cholinesterase, allowing accumulation of large amounts of acetyl-

4

choline.

"Therefore one may look at the poisoning as an excess of

acetylcholine.

'1.bat is acetylcholine?

~at

is it's physiologic

function?
Acetylcholine is a methylated quarternary ammonium saL t found
at nerve terminals in the neuromuscular motor end plate, at all autonomic preganglionic fibers, all parasympathetic postganglionic fibers
and the sympathetic postganglionic fibers supplying sweat glands.
Nerves that liberate an acetylcholine like transmitter are called
cholinergic fibers.
The nerve terminal contains many vesicles which are microscopic
packets containing a constant number of acetylcholine molecules,
roughly 1,000 to 10,000.

An impulse traveling dam a nerve fiber

depolarizes the nerve terminal and releases the acetylcholine.

The

acetylcholine then diffuses across the small gap between the nerve
ending and the ootor end plate.

The end plate has an acetylcholine

receptor complex Which increases the permeability of the end plate
membrane to all ions.

This leads to end plate depolarization. When

the depolarization hits threshold levels an impulse is generated and
the muscle contracts or the nerve impulse is transmitted on in the
case of the ganglion fibers listed above that respond to acetylcholine.
In summary acetylcholine is a chemical mediator necessary for the
transmission of the nervous impulse.

FUNCTIONS OF CHOLINESTERASE
AcetylcrJOline is hydrolyzed almost instantly so that the synapse
5

is ready to transmit a physiologic impulse.

If acetylcholine is al-

lowed to accumulate there is an abnormal increase in function ranging from muscle fasciculations to paralysis.

To prevent the repeti-

tive firing of muscles, the acetylcholine is destroyed or actually
hydrolyzed in a few milliseconds by an enzyme called acetylcholinesterase to choline and acetate.
This action can be represented by the following diagram from
the Biochemistry text of Cantarow and Schepartz5:

tN'~

Cho/i,Jt sle rc IH-e

An anionic site and "esteratic tf site.

lM~

The esteratic site is the

site of fiydrolysis and the one to consider here. When the acetylcholine and the enzyme combine acylation of site X occurs and the
acyl group is transferred from the enzyme to a water molecule.

The

substrate end products are choline and acetate.
There are two general types of cholinesterase.

The first is a

true and very specific enzyme called acetylcholinesterase.

In hu-

mans this is found in nervous tissue and in red blood cells, and has
great functional importance in neurohumoral transmission in muscles
6
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and glands.
The second type is a non-specific
terase and is found in blood plasma.

en~me

called pseudocholines-

Pseudocholinesterase is re-

generated in the liver and therefore is closely related to liver
function.

It is known that when the level of pseudocholinesterase

is lowered by any cause it takes approximately 120 days to regenerate fully; therefore this enzyme reflects the rate of red blood cell
replacement.

As far as it is known pseudocholinesterase does not

have any function in neurohumoral transmission.

It does, however,

break down procaine and succinylcholine.
MEASU~T OF CHOLINESTERA~

Much work has been done tryj.!ilg to find a suitable method of
assaying cholinesterase levels.

Temperature, pH of medium, salts

and ionic strength of media influence the test.

Most m.ethods of as-

saying cholinesterase are based on the determination of the rate of
disappearance of acetylcholine or the rate of formation of acetic
acid from the hydrolysis of acetylcholine.
The most accurate and sensitive methods are the recording
titrimetric and Warburg Manometric procedures in which the amount
of acid is measured stoichiochemically.
The method of Michel is an electro.metric method in which a
change in pH is measured.

This method is not as accurate as the

aforementioned method, but it is suitable for assaying large numbers
of samples.

7

.A field method has been tried, using whole blood and bromothymol

blue as a test baaed on matching the color of glass standards against
the color of reaction mixtures.

So far this methcxl has been un-

satisfactory because of lack of suitable normal standards.
Blood being sent away for analysis should be separated into
cells and plasma.

The samples should be refrigerated to 0 to 50

centigrade.
CHOLINESTERASE INHIBITORS
The cholinesterase inhibitors are rapidly absorbed with contact to the eyes, skin, respirator,y tract, gastrointestinal tract
leading to systemic manifestations of the poisoning.
Insecticides have a high acute toxicity but fortunately are not
as toxic as the "war gases".

So far the agriculture residues on

food have not been a problem because the insecticides break down
rapidly upon exposure to weathering.

Animals whose food is con-

taminated with cholinesterase inhibiting agents do not store the
agent in their bodies.

The pharmacologic action of the cholinester-

ase inhibiting agents is that of inhibiting the enzyme cholinesterase.

The excess acetylcholine that accumulates causes over-stimu-

lation of the parasympathetic nervous system.
by the glands they innervate occurs.

Excessive secretion

The action of excessive

acetylcholine at the myoneural junction can lead to curare like
flaccid paralysis.

Therefore the Cholinesterase-inhibiting agents
8

interfere with respiration by directly depressing the respiratory
center, by paralyzing musoles of respiration, by causing exoessive
respiratory secretion and finally bronchoconst.ric tion.

Many authors

st.at.e that. the bronohoconstriction observed in animals exposed to
these agent.s does not occur in en.
The level of cholinest.erase in both .man and animals can be
gradually depressed without. signs or symptoms; thus the action of
these agents depends on both the degree and the rate of depression.
A point might be made that it takes approximately 90% cholinesterase
inhibition at the respiratory centers to oause respiratory failure.

Thus, considering treataent, even a slight degree of oholinesterase
reactiveation at this oritioal site may relieve failure of respiratory movements.
SIGNS AND SYMPTOMS

The signs and symptoms of antioholinesterase poisonings may
vary in severity, in rapidity of onset, in duration and in range,
depending on the route and magnitude of exposure.

Systemio poison-

ings lead to muscarine-like and nicotine-like effects.

The nicotine-

like effects are usually not seen until muscarine effects have
reached moderate severity.
0Rtic effects

1. Miosis
2. Tearing
3 . Conjunctival hyperemia

9
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.4. Pressure sensation behind eye
5. Headache
6. Funnel vision

7. Blurred vision
Respirato£Y effects
1- Increased respiratory tract secretions

2. Rhinorrhea

3. Nasal hyperemia

4. Tightness in chest
5. Wheezing
6. Dyspnea

,-

7. Pulmonary edema
8. Cyanosis

9. Cheyne-stokes breathing
lO.Respiratory arrest
Gastrointestinal Tract
1. Salivation

2. Anorexia

3. Nausea
4. Vomiting

5. Abdominal cramps
6. Diarrhea

7. Involuntary defecation
Skeletal muscles
10

.-

.

1. Weakness

2. Looal fasiculations

3. Muscle twitching

4. Cramps
5. Paralysis

m9:.!!
1. Increased sweating

Central Nervous System
1. Tension

2. Anxiety

3. Emotional lability

4. Insomnia
5. Exoessive dreaming
6. Slurring of words

7. Depression
8. Confusion

9. Ataxia
10. Grand mal seizures
11. Coma

12. Loss of reflexes
Some authors believe that miosis is an early diagnostic sign,
others feel that the "pin point" pupils should not be relied upon
too much as an early sign.

In general the "eye signs", rhinorrhea,

increased respiratory secretion, tightness in chest, weakness,
11

sweating, abnormal cramps will be seen early or in less severe
poisonings.

Loss of reflexes, convulsions, coma, loss of sphincter

control, such as involuntary defecation or urination are usually
seen in advanced cases.
LABORATORY FINDINGS

Laboratory findings in anticholinesterase poisonings are decreased serum cholinesterase levels,

lelL~ocytosis

and albuminuria.

Frequently acetonuria, glycosuria and hemoconcentration are seen.
In the absence of symptoms there is no electroencephalogram (EEG)
changes.

EKG may demonstrate various A-V blocks ani bradycardia.

The most reliable laboratory finding in making a diagnosis is the
cholinesterase levels.

The cholinesterase levels may be depressed

considerably below normal before signs and symptoms appear.
Grob15 states that he has found evidence of only depressed
cholinesterase levels.

Grob could not find any alterations in the

chemical constituents or formed elements of the blood and no change
in the urine or renal or hepatic function.
PATHOLOGY

The gross or microscopic pathologic findings are not significant.

Evidence of pulmonary or cerebral congestion or changes

secondary to convulsions are often seen.
MECHANISM OF DEli TH

The mechanism of death is due to respiratory failure.

The re-

spiratory failure is due to paralysis both centrally and peripherally.
12
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The peripheral paralysis is brought about by muscle fatigue and the
curare-like blocking of the myoneural junctions of the diaphragm
and accessory muscles of respiration.

This leads to profound anoxia.

The anoxia at first stimulates the chemoreceptors to try to increase
respiratory rate and correct the anoxia.

Continued anoxia rapidly

depresses the respiratory center.
Brown3 described an experiment which proves there is also a
central respiratory failure due to cholinesterase inhibiting agents.
This test was done with Itsarin lt , one of the war gases.

Sarin was

injected intravenously and before the respiratory- muscles were para.lyzed as evidenced by the twitch height of muscles, respirations
ceased.

This occured before anoxia or neuromuscular effects were

demonstrated.

The experimental animals were given a therapeutic

injection of atropine and respiratory stimulant.

The rapidity of

respiratory failure after cholinesterase inhibiting agents were
given and the equally rapid recovery after atropine injection

sea~ed

to leave little doubt about the central origin of respirator,r failure in addition to peripheral failure to paralysis.
The profound anoxia and the increasing accumulation of acetylcholine in the nervous system leads to intermittent and then almost
continuous grand mal seizures until flaccid paralysis supervenes.
The anoxia and acetylcholine affect the cardiovascular system.
The anoxia at first initiates hypertension but if the anoxia is not
improved the blood pressure completely falls leading to circulatory
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collapse.

A cholinergic effect of acetylcholine is bradycardia.
TREATM8:NT

Grob12 gives this method of treating anticholinesterase poisonings.

These are not necessarily the preferred order of treatment.
1. Remove from exposure
2. Decontaminate

3. Remove secretions

4. Maintain adequate airway
5. Apply artificial respiration if needed
6. Administer atropine

7. In severe cases

-.

a~~nister

oximes (2-PAM)

8. If convulsions present, treat with trimethadions (Tridione)
The patient should be removed from exposure.

This$ep is not

important with poisonings due to ingestion but it is vitally important when dealing with the "war nerve gases lf or insecticides.
If the patient is still absorbing poisons from the skin or lungs
due to contamination of the environment he will become more toxic
while you are treating him.
Medical judgment is as important in treating anticholinesterase
poisonings as any other acute medical emergency.

Decontamination

should begin as soon as possible, however, one should not direct
all the attention t.p decontamination 'when respiration has ceased.
There are some unusual situations that must be consj.dered here.
Physicians must remember that these compounds are readily absorbed

14

throl.l.gh the skin and airways.

Therefore attendants should remember

to protect themselves from contamination.

Non-military poisonings

can probably be dealt with merely by wearing rubber gloves to prevent skin contamination.

Volatile compounds can contaminate the

atmosphere making special individual protection such as gas masks
and protective clothing necessary.
Decontall1.ination of gastrointestinal tract should be carried
out by prompt induction of emesis.

Durham and Hayes article 9

states that experiments have indicated that vomiting induced immediately or even l~ hours after ingestion is more effective then
gastric lavage in removing poison.

Induce vomiting and then give

some neutral material such as water or milk and induce the vomiting
again.

Vomiting should never be induced if the patient is uncon-

scious unless an endotrachial tube ia inserted beforehand.

If the

patient is unconscious, or the vomiting profuse, gastric lavage may
be done with

5%

sodium bicarbonate.

All contaminated clothing must be

rerr~ved

as quickly as possible.

Care must be taken to prevent contamination during the disposal of
the clothes.

The clothing should be buried rather than burned.

Vapors released from burning contaminated materials could contsll1inate the surrounding atmosphere.
The patient should be washed with soap and lots of water.
Care should be taken to avoid abrasion of the skin, for this would
speed up absorption of the poison.

15

Once the skin appears clear,

bathe

~th

ethyl alcohol.

insecticides and the oil based

~ny

cholinesterase inhibitors are more soluble in alcohol than in water.
The eyes absorb the anticholinesterase agents remarkedly rapid.
If they are suspected of being contaminated, irrigate them with
physiologic saline or tap water.
The upper respiratory tract lihould be suctioned to re!IX)ve secretions.
ble.

Endotraoheal intubation should be done as soon as possi-

Intubation helps maintain an adequate airway and it certainly

helps aspirating the thick mucus which might prove to be very difficult with a rubber oatheter being passed alone down the trachea.

A

tracheostomy may be necessary but most authors agree that intubation

-

is superior in that it can be done very rapidly, and the patient is
not subjected to the hazards of tracheostomy.

)Jost physicians a-

gree that, if an airway must be maintained over twenty-four to
forty-eight hours, a tracheostomy should be done; but response to
specific therapy of anticholinesterase poisoning is so rapid usually
that tracheostomy is not needed.
Artificial respiration must be given if respiration has either
failed or is inadequate.

A note of caution should be given on

mouth-to-mouth respir'ation on a "nerve gas!! casualty.

The adroin-

istrator could become a victim of the same lethal chemical agent.
This author has not read any articles reporting

poisordr~

to the

adrdnist.rator of mouth-to-mouth respiration of an insectidde type
of Cholinesterase-inhibiting agent.

16

A mechanical respirator with a non-rebreathing valve could be
most ideal and one should be procured and maintained at the bedside
even if the casualty does not need it immediately.

The patient

should be watched very closely for at least forty-eight hours for
sudden respiratory arrest.

Sudden respiratory

arrests have been

known to occur i..'1 the first forty-eight hours even though the patient
appears to be responding well clinically.

The administration of atropine is specific for anticholinesterase poisoning.

The intravenous route is the preferred .rrethod of

administration because the effects are seen within four minutes
and are maxirr..al in eight minutes.

Atropine should be given as soon

as possible.
Wills et a1 23 states that atropine must be given within one
minute of severe exposure to sarin, a nerve gas, if treatment is to
be effective.

The reason for this is that death occurs very rapidly,

usually within a few minutes after severe exposure to sarin.

This

author has not read any articles in the review of literature that
gives a time limit to the effectiveness of atropine in insecticide
poisoning of the anticholinesterase type.

One

ass~~es

atropine

will be beneficial if given at any time during the course anticholinesterase poisonings,

assur~g

the patient lives long enough

after adnli.n,istration for the pharmacologic action to occur.
The point being, the atropine must be given within a few min-

17

utes in severe poisoning in order to save the patients life but
can also be very helpful in mild to moderate poisonings if given
for the first time several hours after exposure.
The antidote effect of atropine in anticholinesterase poisonings is not due to any action on, or neutralization of the anticholinesterase compound.

Atropine merely serves to block certain

actions of the excess acetylcholine accumulated.

Atropine speci-

fically blocks the muscarinic actions of acetylcholine such as
glandular secretion, and slovdng of the heart.

It is also specific

to reverse the effects of anticholinesterases in the central nervous system especially the central respirator,y center.

Atropine

has absolutely no effects on the nicotine-like effect of excess
acetylcholine.

These effects are increased fatigability, general-

ized weakness, involuntary muscular twitching, muscle cramps,
fasciculations and muscular paralysis.
Atropine will not prevent respiratory failure due to respiratory muscle paralysis nor will it restore strength to respiratory
or pharangeal muscles.
The symptoms of atropine if administered to a normal subject
are dryness of mouth, pharynx, a slight difficulty in swallowing,
dilated pupils, dry flushed skin, blurry near vision, subjective
feeling of warmth, slight tachycardia, mild drowsiness, slowness
of memory and occasionally hallucinations.

18

DOSAGE OF ATROPINE
Most authors recoIn.!Ilend t'WO to four milligrams intravenous
atropine to be given as soon as cyanosis is overcome.

Atropine in

doses of two milligrams given intravenously should be given at five
to ten minute intervals until signs of over atropinization appear
(see above symptoms of atropine) or until symptoms are relieved.
Poisonings by anticholinesterase compounds increase the tolerance
for atropine.

A severely poisoned individual may take as many as

forty milligrams or more before signs of over atropinization are
produced.

A mild degree of over atropinization should be maintained

for twenty-four hours in a mild poisoning case, and forty-eight
hours in a severe case.

Over atropinization may be a little inca-

pacitating but presents little challenge to life.
Atropine should not be administered for preventative purpose
in persons who anticipate exposure to the "nerve gases" or contamination while working with various insect.icides.

The reason for this

is that this may mask early symptoms, increase respiratory absorption of the anticholinesterase by inhibiting bronchial secretion,
and in general allowing the person to expose himself to higher
levels of poisoning without warning.

Atropine itself may render a

person unfit for his occupation.

CONTRAINDICATIONS FOR USE OF ATROPINE
The use of atropine in anticholinesterase poisonings is contraindicated in one very important situation.

19
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This situation is the

anoxic patient.

Granted it has been pointed out that atropine must

be given as soon as possible if death is to be prevented in serious
cases.
~

However if the patient is cyanotic or anoxic this condition

be corrected by artificial respiration and oxygen first.

known that atropine releases the heart from vagal control.

It is

The

tachycardia that occurs leads to an increased work load on the cardisc muscle.

The increased strain on the heart in face of severe

anoxia will often lead to immediate ventricular fibrillationrsnd
death.
0.5% atropine opthalmic solution may be locally applied to
the eye to relieve the ocular symptoms produced by local absorption
of anticholinesterase agents.

Often systemic atropine does not

relieve the miosis.

There has been much investigation in the past few years into
agents that would reactivate cholinesterase.
peared to be with the oximes.
to be 2-PAM chloride.

The most success ap-

The most successful oxime appears

This is 2-pyridine aldoxime methochloride.

Its chemical structure is:

The specific activity of 2-PAM rests in the 2-formyl-l-methyl20

pridinium ion and

~independent

of the particular salt used.

Chlo-

ride, iodide, methylsulfate and methane sulfonate salts have been
used and tested.

The chloride is preferred because of better water

solubility at all temperature, a higher potency per gram and fewer
side effects.
2-PAM chloride is capable of reversing the combination between
a cholinesterase molecule and the inhibitor causing reactivation of
cholinesterase.

2-PAM chloride does not replace the need for atro-

pine in treatment of

anticholinester~se

poisonings because the

oximes and atropines have different sites of action.

It is prefer-

able to use these two agents in combination and take advantage of
the antidotal effects of both at their different sites of action.
It is thought 2-PAM potentiates the action of atropine, and increases the signs of over atropinization.

The mechanism of action

for this may be due to 2-PAM reactivating the cholinesterase and removes the accumulated actylcholine, leaving the large doses of
atropine to give an unopposed drug effect.
The mechanism of action of 2-PAM in regenerating the inhibited
cholinesterase is thought to be due to direct combination with the
phosphorus inhibited enzyme.

2-PAM aids or causes a reaction in

which the phosphorus moiety is split off and hydrolyzed.

2-PAM

residue appears to undergo a further reaction to regenerate the
active enzyme.

The important thing from a practical point is that

2-PAM has a greater affinity for the phosphorus moiety than does
21

the enzyme.

ROUTES OF ADMINISTRATION
2-PAM can be administered intravenously, intramusculary, orally
Subcutaneously and has some penetration to the cornea when applied
topically.

The preferred route is intravenous administration be-

cause it is immediately dispersed throughout the extra cellular
water and gives a high plasma level.
DOSAGE

The usual adult dOlle is 1000 milligrams initially and this can
be injected directly in the vein at a rate not to exceed 500 milligrams per minute.

The dose may also be mixed in 250 cc of saline

and given over a thirty minute period.

Ii

second dose of 1000 mil-

ligrams of 2-PAM can be given one hour after initial dose if muscular weakness persists but caution should be used and facilities
to maintain respiration should be in readiness for 2-PAM in high excessive doses is a weak anticholinesterase agent itself.
The dose for children is 25 to 50 milligrams per kilogram.
2-PAM is promptly and adequately absorbed orally.

Marked drug

effect is seen in thirty minutes and persists for approximately ten
hours.

The drug is probably not completely absorbed and some non

excretory prooess are operated by this route so the dosages and
dosage intervals are different in oral route.
One to four grams may be given orally on initial dose depending
on severity of poisonings.

lti.ld cases usually show full remission
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in one hour when one to two grams are given orally.

This dose may

be repeated after three hours i.f necessary.
SIDE EFFECTS

The side effects of 2-PAM on normal subjects are dizziness,
blurred vision, diplopia, headache, impaired accomodation, nausea,
slight transient tachycardia.

There are no demonstrable changes on

blood pressures, EKG, respiration, urinalysis, liver function tests,
bleeding or clotting times.

No irritation at site of extravasation

on intramuscular injection.

In general 2-PAM appears to feature a

low toxicity.
The time limit that 2-PAM must be administered after anticholinesterase poisoning, to be maximally effective is not known.

It is

felt that administration of 2-PAM thirty-six hours after exposure is
not too beneficial.
TREATMENT OF CONVULSIONS

Patients with severe anticholinesterase poisonings may develop
convulsions.

If the convulsion interferes with artificial respira-

tion and oxygen therapy, treat with trimithadione, one gram intravenously every fifteen minutes until controlled.
ether may be given.

Barbituates or

The action of succinylcholine increases the

effect of anticholinesterase agents, thus the use of this

relaxa~t

is contraindicated.
Care must be taken in administering barbituates, anticholinesterase poisoning sensitizes the medullary centers to depression by
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barbituates.

CONTRAINDICATED DRUGS
Morphine, theophylline, aminophylline, are strictly contraindicated in these cases.

Smoking should be forbidden as this increases

the respiratory and gastrointestinal symptoms.
Tranquilizers should be used with great caution.

Som of the

phenothiazine derived tranquilizers are suspected to potentiate certain anticholinesterase agents.
PROGNOSIS
If death does not intervene, recover,y from anticholinesterase
poisonings is usually complete.

However the cholinesterase level

may remain low until regeneration restores normal level.

Patients

are very susceptible to even small exposures of anticholinesterase
until this level is restored.

This point should be seriously con-

sidered when further exposure is an occupational hazard.
Miosis and headaches are often the only residual effect and
this is a minor one compared to the seriousness of this type of
poisoning.

They usually respond well to topical application of 0.5%

atropine to the eyes.

MASS CASUALTIES
If the cholinesterase-inhibiting agents are ever used as a "war
gas" it would present many problems. Many of these problems are
similar to those in all wars, some are new.
The problems are to initiate treatment quickly, decontaminate,
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have as few sites as possible giving treatment and thus reduce
problems of supply, to keep from contaminating all of the medical
station, get maximum use out of equipment, and finally to set up
a system where the lowest number of medical personnel can maintain
the largest possible number of casualties.
Clinically the problem of separating the types of injury, determining the seriousness of injury and routing the patient to
properly equipped medical station to care for a given injury is a
basic problem of triage.
There oould be a high number of oasualties in a short period
of time.

These oasualties could be in different states of inca-

pacity.

One of the first problems is to make a diagnosis of anti-

cholinesterase poisonings.

Good military intelligenoe forewarning

of attack is of great importance.

A good rule may be to consider

all attacks on the United states to inolude "nerve warfare" until
proven otherwise.

Certainly whenever the first proven case of

anticholinesterase poisoning is found the information should be
sent to all medical facilities in the area.

A definite plan of

communication should be made because speed is of utmost importance.
A disaster plan covering nerve gas attacks should be initiated in
suoh a way that administration and communication are given the
highest consideration. Mass panic and confusion could be one of
the greatest dangers to nerve gas attack. Well trained medical
teams can handle many seriously poisoned patients at once if they
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know immediately what type of poisoning has occurred.
People respond amazingly well in stressful conditions that
have not been experienced before if they have good leadership and
have given consideration to a proposed plan of action.
ing situations panic people and reduce judgment.

All terrify-

It is easy to

understand that a plan is needed to get work properly directed and
organized.

Leadership must be assumed at all levels.

Leadership

is most effective when key command personnel understand the situation and know what needs to be done.
Determining the seriousness of anticholinesterase poisoning
of a given individual in a mass casualty situation is complicated by
lack of time and an over burdened laboratory.
putedly no good.

Eye signs are re-

Serum anticholinesterase levels can't be run on

hundreds to thousands in time to be effective.
Cyanosis, respiratory arrest, coma, convulsions or flaccid
para~sis

are definite signs of serious poisoning and demand that

vigorous and immediate treatment be given.
All patients should enter only one entrance and quickly be
screened.

It is very important to quickly designate and limit the

contaminated area.

A certain number of Doctors, Nurses and other

medical personnel will be casualties due to initial attack, placing
an added burden on those remaining.

The remaining staff must take

immediate steps to protect themselves from contamination from the
patients.

The screening station personnel should be protected with
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gas masks, chemically impregnated or rubber impermeable suits and
rubber gloves.
Assuming that all patients are nerve gas casualtiesconly,
which greatly reduces the screening problems, the following system
may be used.

The first screen by a doctor taking only seconds per

patient could separate the critically poisoned patients using the
signs stated above as critera, from the lesser poisoned ones.

The

patients showing signs of poisoning but still capable of walking and
breathing unassisted at the moment at least, could form a line where
several nurses could quickly administer I.V. atropine or 2-PAM if
necessary.

This procedure hopefully taking only seconds per patient

if the nurses are constantly resupplied so tbe,y do nothing but administer atropine.

The use of signs or of one individual leading

a group of ten to twenty people could lead these patients to an
area where they could remove all their clothing.
separated from the women if facilities permit.

The men could be
These people could

be led to showers where they decontaminate themselves with soap and
wa ter, taking extra care to thoroughly wash the hair a nd fingernails.
Again one person could supervise the shower to supply soap, give
instructions and keep the patients moving.

The patient being de-

contaminated could be given clothing and moved into another part of
the medical aid station that is not contaminated.

The g.coup could

then use the "buddy system" to observe on another and report any
difficulty in breathing.

A smaller medical team could then treat
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this large group because hopefully they aren't as seriously poisoned
and maybe only I.V. atropine is necessary.

If they become seriously

poisoned they should be transferred to maximum care section immediately where personnel and. equipment is available.
Returning to the first screening station let us follow the
handling of a seriously poisoned patient.

These patients should be

separated from the less serious patients and be di. rected toward intensive care.

The next station and very close by, should have a

doctor and nurse acting as a team.

The doctor can insert an endo-

tracheal tube quickly, suction out the respiratory tract and evaluate
the patient further.
and 2-PAM.

The nurse would immediat ely gi V'e 1. V. atropine

It must be remembered that atropine cannot be given

while cyanosis is present.

The patient should then be quickly

moved to a permanent high intensive care station freeing the second
station to take care of another patient.
The third station is also an intermediate station being set up
to administer drugs, 02' and suction.
tected against contamination.

All personnel should be pro-

The purpose of this station is to

decontaminate the patient and still maintain him.

This station

needs to be staffed by many more personnel so decontamination can
be done quickly to a patient Who cannot help himself.
The fourth station, the uncontaminated high intensive care
area, should be arranged in groups of four.

The patients could be

arranged in a small square with their heads together.
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A centrally

located suction machine could then be used to keep the airways open
without moving the machine muCt'1.

Large mass casualty situations

may require expanding the number to more than four.

One person

could keep a number of airways open using this technique.

A cer-

tain amount of sterile technique would have to be overlooked as a
sterile tube could not be placed down each individual as the suction
machine is being used.
b~tics

When the time and situation permits anti-

could be given, if needed, to treat resultant respiratory

infection.
The time element as in all poisonings is very important but
this problem compounds the seriousness of the disaster if thousands,
if not hundreds of thousands are affected at the same time.
posed people need help immediately and
stations in tLme.

w~y

Ex-

not get to medical aid

Existing rescue services is not the answer.

They would either be quickly swamped with work and could not get
to aid all needing help or the rescue teams themselves might be
poisoned.
Equipment and drug requirements may be another source of
failure to adequately handle mass casualties.

Most

2~

tals probably have less than ten artificial respirators.

bed hospiEndo-

tracheal tubes are probably more abundant but would fall short of
hundreds that may be needed all at once.
According to Dr. Charles W. Steele, speaking before the ninth
ar~ual

U. S. Civil Defense Counsel Conference at Minneapolis in
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September, 1960, tlif all the atropine available to civilian defense
authorities were distributed among physicians, each physician would
have about 6 doses or less than the amount needed for one severe
case of poisoning."
Robert A. Lehaan, the Vice President and Research Director of
Campbell Pharmaceuticals, Inc., 121 East 24th Street, New York 10,
New York, states the 2-PAM (Protopam Chloride) will be available
for general distribution by his company around January 1964.
sently this drug is available on a research
The drug shortage is evident, however.

basj~

Pre-

only.

Stockpiling the drug

might not solve the problem as the time necessary to distribute

-

the drug from supply areas might for all practical purposes nullify
the usefulness of t he drug.
Today the most basic protection against the nerve gases is to
have good military intelligence to warn of imminent attack and completely evacuate the area.
Presently 2-PAM chloride is being considered for use as a
prophylactic agent to protect against nerve gases.
complete on its prophylactic use.

Studies aren't

The success of 2-PAM as a definite

therapeutic agent in poisoned eases leaves hope that it may also
be used as a pre-exposure protecting agent.
SUMMARY
The cholinesterase inhibiting agents considered here are organic phosphorus compounds which irreversibly bind the enzyme
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cholinesterase.

This action blocks the hydrolysis of acetylcholine

and acetylcholine is allowed to accumulate.

Excessive acetylcholine

at the myoneural junction decreases its function and can lead to
flaccid paralysis.

The accumulated acetylcholine also over stimu-

lates the parasympathetic nervous system causing excessive secretions by the glands they innervate.

This type poisoning manifests

muscarine-like and nicotine-like effects.

The muscarine-like ef-

fects include nausea, vomiting, diarrhea, excessive salivation,
sweating and dyspnea.

The nicotinic-like effects are muscular

weakness, fasiculations, cramps and finally paralysis.
anism of death is due to respiratory failure.

The mech-

Treatment involves

maintaining respiration and directing medical attention towards
breaking down the cholinesterase block which is irreversible without drug intervention.

Oximes such as 2-PAM (2-pyridine-aldoxime-

methochloride) are specific in action of reactivating the enzyme
cholinesterase and reacting chemically with the anticholinesterase
agent.

Atropine therapy is also specific for symptomatic

contr~

of excessive glandular secretion caused by the accumulated acetylcholine.
Common sources of anticholinesterase poisoning are from insecticides such as parathion, matathion, chlorthion, phorate and other
organic phosphorus compounds.

The military war gases, the "nerve

gases", such as sarin (isopropylmethylphosponofluoridate) are very
potent anticholinesterase agents.
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The treatment is the same for

all the above agents.
Treatment of a severe case of anticholinesterase poisoning with

coma, cyanosis or respiratory distress present.
1.

Maintain Airway
A.Endotracheal intubation.
B. Suction airway.

2.

Artificial respiration
A. Use a positive pressure method of artificial respiration
because of possible respiratory muscle

para~sis

and a

restricted airway.
B. If a mechanical respirator is not used, then watch patient
very closelY for sudden respiratory arrest.
C. Cyanosis must be corrected before atropine can be administered otherwise there is great possibility of inducing
ventricular fibrillation.

3.

Atropine Administration
A. Adults:
1. Give 2 to 4 mg atropine intravenously.
2. Repeat dosage at 5 to 10 minute intervals until signs
of atropinization appear.

3. A mild degree of atropinization should be maintained
for 48 hours.

(Dry, flushed skin, tachycardia.)

B. Children
1. 1 mg per square meter surface area.

32

4.

2-PAM Chloride therapy (2-Pyridine-Aldoxime-Methochloride).
A. Adults.
1. 1000 mg 2-PAM intravenously at a rate not to exceed
500 mg per minute.
2. The above dose may be repeated in one hour if muscle
weakness has not been relieved.

Additional doses may

be given if muscular weakness persists, however, caution
must be used because 2-PAM is a weak anticholinesterase
agent itself.

3. 2-PAM can be given orally, intramuscularly, or subcutaneously i f intravenous method is not feasible.
B. Children.
1. The dosage of 2-PAM is 25 to 50 mg per kg.

C. 2-PAM may be obtained from Campbell Pharmaceuticals, Inc.,
121 East 24th Street, New York 10, New York.

5. Decontaminate Patient.
A. Medical personnel should protect themselves against contamination by wearing rubber gloves.
B. Remove patients clothing and wash skin with soap and water.
C. Then wash with alcohol

sL~ce

many anticholinesterase are

more soluble in alcohol than in water.
D. Wash eyes with physiologic saline or tap water.
E. If ingestion has occurred induce

a~esis

lavage with 5% sodium bicarbonate.
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or give gastric

6.

Convulsions.
A. If conwlsions occur treat with one gram Trimethadione

(Tridione) intravenously every 15 minutes until controlled.
Barbituates or ether may be used with caution.

7.

Contraindicated Drugs.
A. Morphine, theophylline, aminophylline, succinylcholine

and phenothiazine derived tranquilizers are contraindicated.

B. Smoking should be forbidden as this increases respiratory
and gastrointestinal symptoms.
8.

Observe Patient.

A. The patient should be observed for at least 24 hours after
symptoms have subsided because fatal relapses can occur
due to continuing absorption of the poison or the dissipation of the effect of the antidote.

9.

J/rlld Cases of Poisoning.
A. Mild cases demonstrating only headaches, blurred vision

and mild

rr~scarinic

signs can be treated by decontaminating

the patient and giving 1000 to 2000 mg 2-PAM chloride
orally in a single dose.

This treatment usually gives

full renussion of symptoms in one hour.

The patient must

be kept under medical supervision for at least 24 hours.
If 2-PAM is not available, mild cases can often be controlled by atropine thera py alone.
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Remember that 2-PAM

is specific for reversing the choli.nesterase inhibitor
and that atropine can only block the parasympathetic
activity.

CONCLUSI0r!
The anticholinesterases are the basis of many insecticides
and of nerve gas warfare.

The potential and hazards of these a-

gents are not well known.

Severe poisoning by either agent CQuld

cause death in minutes.

Nerve gas has the potential to kill 80%

of the population in a several thousand square mile area.

The

seriousness can be compared to the well heralded atomic warfare
potential that can destroy 50% of the population over a few hundred

-

square mile area.

Much education, planning and preparation for

protection against atomic war by the public has occurred in the
past 15 years.

Very little has been said about nerve warfare.

This author feels that many physicians don't understand the
problems in the treatment of anticholinesterase poisonings.

This

lack of knowledge may cause the delay in treatment while the Doctor is getting this information.

The delay mlly lead to death in

a seriously poisoned patient.
Mass casualty poisonings such as those that could occur vdth
use of the "nerve gases lt could find the nation unprepared medically.
The increased use of insecticides may present more poisonings by
these agents in the future.

The drugs necessary of specific treat-

ment aren't generally present in most centers in either type or
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amount.

2-PAM is available only for research use.

Atropine, a

common drug, is normally used in very small quanti ties.

How many

hos pi tals or clinics could supply the amount of atropine necessary
to treat several patients requiring 40 mg a day for each patient?
Immediate lack of mechanical respirators, endotracheal tubes and
protective clothing adds to the medical state of unpreparedness to
prevent mass homocide in nerve gas warfare.
The only sound solution to this problem is to develop a prophylactic drug protecting against anticholinesterase poisoning and
the production and distribution of the drug making it available
for immediate use.

2-PAM appears to have the most promise to meet

these demands but a more active research program and national concern of this problem is necessary.
itself to a national program
oral polio vaccines.

A prophylactic drug could lend

s~~r

to that carried out with the

The drug could be distributed to the popu-

lation so that it would be ready for immediate use in the event
of imminent exposure.

A smaller scale program could prevent in-

dustrial poisonings to labors working with insecticides.
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